Explore 3 Stock Ideas & Industry Insights Download Free Report

888-969-2592
Shopping Cart 0
countryflagCA
Login

Home CompaniesAccendra Health Inc

Accendra Health Inc

Healthcare Medical Distribution
PortfolioPortfolio WatchlistWatchlist
Company price
0.20005 USD -0.00 ( 1.50%)
Last update at 2026-11-09T15:19:00Z
VOLUME
344548
Market Cap
85.36M

Momentum Score

…

Accendra Health, Inc., together with its subsidiaries, operates as a healthcare solutions company in the United States. It offers a range of products and services for in-home care and delivery for diabetes treatment; home respiratory therapy, including home oxygen and non-invasive ventilation services; obstructive sleep apnea treatment, such as continuous positive airway pressure and bi-level positive airway pressure devices, and patient support services. The company also supplies other home medical equipment, patient care product lines including ostomy, wound care and negative pressure wound therapy, urology, incontinence, and other products and services. It serves patients and home health agencies. The company was formerly known as Owens & Minor, Inc. and changed its name to Accendra Health, Inc. in December 2025. Accendra Health, Inc. was founded in 1882 and is based in Glen Allen, Virginia.

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Day Price Range
0.20
Low
0.21
High
52 Week Price Range
0.93
Low
5.69
High

Momentum Score

…
Loading momentum score…

A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.

Score - Rating
>= 1 - Low / > 1 but < 2 - Below Average / > 2 but < 3 - Average / > 3 but < 4 - Above Average / > 4 - High
AI Summary

Accendra Health Inc (NYSE: ACH) is a publicly listed healthcare company; available public disclosures are limited, so its core operations, end markets and growth drivers are not well documented. Investors may find potential exposure to the healthcare sector of interest but should await clearer filings that disclose strategy, revenue sources and execution milestones.
The principal risk is the lack of transparent public information creating uncertainty about its business model, financial condition, regulatory exposure and execution, making ongoing regulatory filings and financial reports essential to monitor.

Risk Score
High

Note: The summary and risk score provided above is created by AI and should not be construed as a recommendation of Kalkine.

Key Metrics*

Previous Close
0.20
Dividend Yield
-
Revenue TTM
2647.25M
Revenue Per Share
34.53
Gross Profit TTM
1186.89M
Debt / Equity
-4.85
ROE
-198.35%
Net Debt
1951.79M
ROCE
1.81%
Diluted EPS TTM
-1.44

Key Financials*

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Income before tax -101.95M -357.36M -54.73M 10.89M 276.75M
Net income -1100.64M -362.69M -41.30M 22.39M 221.59M
Selling general administrative 1067.56M 1909.77M 1813.56M 1554.82M 1077.06M
Selling and marketing expenses - 0.02M 0.02M 0.02M 0.01M
Gross profit 1201.61M 2219.16M 2125.16M 1826.35M 1513.23M
Reconciled depreciation 214.52M 264.77M 287.38M 228.67M 90.62M
Ebit 27.25M -213.55M 103.19M 139.78M 324.84M
Ebitda 241.77M 51.22M 390.57M 368.45M 415.46M
Depreciation and amortization 214.52M 264.77M 287.38M 228.67M 90.62M
Operating income 150.16M -207.77M 104.51M 142.91M 368.47M
Other operating expenses 2611.88M 10908.65M 10229.46M 9812.56M 9416.84M
Interest expense 129.20M 143.80M 157.91M 128.89M 48.09M
Tax provision 0.73M 5.33M -13.43M -11.50M 55.16M
Interest income 107.18M 143.80M 157.91M 128.89M -
Net interest income -107.18M -143.80M -157.91M -128.89M -48.09M
Extraordinary items -997.96M -11.95M -50.21M 0.00M -
Income tax expense 0.73M 5.33M -13.43M -11.50M 55.16M
Total revenue 2762.03M 10700.88M 10333.97M 9955.48M 9785.32M
Total operating expenses 1051.45M 2426.92M 2020.65M 1683.44M 1144.76M
Cost of revenue 1560.43M 8481.73M 8208.81M 8129.12M 8272.09M
Total other income expense net -252.11M -149.59M -159.23M -132.02M -91.72M
Net income from continuing ops -102.68M -362.69M -41.30M 22.39M 221.59M
Net income applicable to common shares -1100.64M -362.69M -41.30M 22.39M -
Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Total assets 2451.76M 4656.16M 5093.32M 5386.28M 3536.55M
Intangible assets 136.47M 296.73M 361.83M 483.74M 243.75M
Other current assets 95.54M 149.51M 150.89M 128.64M 88.56M
Total liab 2912.74M 4090.93M 4169.16M 4440.68M 2598.05M
Total stockholder equity -460.98M 565.23M 924.17M 945.60M 938.50M
Other current liab 290.24M 576.58M 311.04M 324.34M 298.21M
Common stock 152.78M 154.40M 153.09M 152.56M 150.87M
Capital stock 152.78M 154.40M 153.09M 152.56M 150.87M
Retained earnings -1079.75M 6.02M 368.71M 410.01M 387.62M
Good will 1228.14M 1331.28M 1638.85M 1636.70M 390.19M
Other assets 174.03M 2.00M 149.35M 150.42M -
Cash 281.99M 49.38M 243.04M 69.47M 55.71M
Cash and equivalents 281.99M 49.38M 243.04M 69.47M -
Total current liabilities 947.08M 1873.74M 1891.88M 1566.47M 1344.02M
Current deferred revenue - - 116.40M - -
Net debt 1951.79M 2090.43M 2162.56M 2723.68M 1097.92M
Short term debt 293.27M 45.20M 292.57M 94.71M 43.85M
Short long term debt 250.00M 40.00M 206.90M 17.91M -
Short long term debt total 2233.78M 2139.81M 2405.60M 2793.15M 1153.63M
Other stockholder equity 466.88M 454.15M 434.19M 418.89M 440.61M
Property plant equipment 365.26M 864.97M 840.50M 858.93M -
Total current assets 547.87M 2021.02M 2102.79M 2295.18M 2321.81M
Net receivables 95.91M 690.24M 598.26M 763.50M 681.56M
Long term debt 1799.88M 1799.12M 1890.60M 2482.97M 947.54M
Inventory 74.44M 1131.88M 1110.61M 1333.59M 1495.97M
Accounts payable 363.56M 1251.96M 1171.88M 1147.41M 1001.96M
Accumulated other comprehensive income -0.89M -49.34M -31.82M -35.85M -40.59M
Non currrent assets other 172.69M 134.04M 149.35M 96.26M 53.24M
Non current assets total 1903.89M 2633.14M 2990.53M 3091.10M 1214.74M
Capital lease obligations 70.32M 300.69M 222.43M 215.47M 162.24M
Long term debt total 1799.88M 1808.05M 1890.60M 2482.97M -
Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Total cashflows from investing activities 144.42M -116.53M -137.25M -1804.48M -53.63M
Net borrowings 203.50M -244.20M -416.69M 1582.50M -81.44M
Total cash from financing activities 188.08M -267.60M -417.33M 1497.11M -129.48M
Net income -102.68M -362.69M -41.30M 22.39M 221.59M
Change in cash 232.61M -223.54M 186.74M 14.15M -62.47M
Begin period cash flow 49.38M 272.92M 86.19M 72.03M 134.51M
End period cash flow 281.99M 49.38M 272.92M 86.19M 72.03M
Total cash from operating activities -101.79M 161.50M 740.71M 325.01M 124.18M
Issuance of capital stock - - - 0.00M 0.00M
Depreciation 95.83M 264.77M 287.38M 228.67M 90.62M
Other cashflows from investing activities 144.42M 94.33M 53.62M 46.71M 39.43M
Dividends paid - - 0.00M 0.00M 0.73M
Change to inventory -6.85M -26.23M 224.34M 166.56M -263.44M
Change to account receivables 122.36M -94.55M 166.58M 1.10M -2.20M
Sale purchase of stock -10.18M 0.00M 0.00M 0.00M -
Other cashflows from financing activities -5.24M -23.41M -0.64M -85.39M -33.40M
Capital expenditures 190.96M 228.16M 207.89M 166.58M 49.69M
Change in working capital 74.21M -25.44M 522.29M 89.77M -261.40M
Stock based compensation 12.00M 26.84M 23.22M 20.99M 25.02M
Other non cash items -181.15M 284.12M -27.22M -10.45M 78.09M
Free cash flow -292.75M -66.67M 532.82M 158.42M 74.49M

Peer Comparison*

Sector: Healthcare Industry: Medical Distribution

Stock Name
Change
(USD)
Price
(USD)
Trailing
PE (x)
Forward
PE (x)
Price Sales
TTM (x)
Price to Book Value (x)
Enterprise Value
to Revenue (x)
Enterprise Value
to EBITDA (x)
ACH
Accendra Health Inc		 -0.00
1.50%		 0.20 - 2.86 0.03 1.07 0.70 7.03
MCK
McKesson Corporation		 -1.08
0.10%		 1059.76 24.45 20.41 0.26 5.04 0.27 15.03
COR
Cencora Inc.		 7.84
2.35%		 341.40 24.22 16.39 0.19 20.41 0.21 13.72
CAH
Cardinal Health Inc		 2.84
1.05%		 274.56 29.48 17.92 0.20 16.07 0.22 15.67
HSIC
Henry Schein Inc		 1.75
2.03%		 87.80 25.89 15.08 0.72 3.14 1.00 13.43

Profile*

Accendra Health Inc

Accendra Health, Inc., together with its subsidiaries, operates as a healthcare solutions company in the United States. It offers a range of products and services for in-home care and delivery for diabetes treatment; home respiratory therapy, including home oxygen and non-invasive ventilation services; obstructive sleep apnea treatment, such as continuous positive airway pressure and bi-level positive airway pressure devices, and patient support services. The company also supplies other home medical equipment, patient care product lines including ostomy, wound care and negative pressure wound therapy, urology, incontinence, and other products and services. It serves patients and home health agencies. The company was formerly known as Owens & Minor, Inc. and changed its name to Accendra Health, Inc. in December 2025. Accendra Health, Inc. was founded in 1882 and is based in Glen Allen, Virginia.

4435 Waterfront Drive, Glen Allen, VA, United States, 23060

(804) 277-4304

https://www.accendrahealth.com

6500

Name Title Year Born
Mr. Edward A. Pesicka President, CEO & Director 1968
Mr. Jonathan A. Leon Executive VP, CFO & Corporate Treasurer 1967
Mr. Perry A. Bernocchi Executive VP & COO 1959
Mr. Heath H. Galloway Executive VP, General Counsel & Corporate Secretary 1977
Will Parrish Vice President of Strategy of Corporate Development, & Investor Relations NA
Mr. Dirk Benson Chief Commercial Officer NA
Mr. Colin Bain Chief Products Officer NA
Trudi Allcott Director of Media Relations NA
Mr. Nicholas Piecora Senior VP & Chief Information Officer NA
Ms. Agnes Ansay VP & Chief Procurement Officer NA

Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.

Kalkine

3 Mining Stock
Ideas Report

Download a free report with stock ideas and industry insights for general information.

Download Free Report Now → sector image

Top Stocks by Market Cap*

GFR
CAD 10.96
+38.15%
MOON
CAD 4.83
+9.64%
PDN
CAD 8.13
+7.68%
BDT
CAD 72.82
+6.65%
HG
CAD 4.28
+6.20%
CSU
CAD 3300.00
-6.42%
CURA
CAD 12.68
-4.16%
DIV
CAD 3.93
-3.44%
SOIL
CAD 7.18
-3.10%
OBE
CAD 13.31
-2.92%

Equity Sectors*

  • Basic Materials

    +3.63%

  • Communication Services

    -1.14%

  • Consumer Cyclical

    +0.75%

  • Consumer Defensive

    -0.36%

  • Energy

    +2.18%

  • Financial Services

    +1.33%

  • Healthcare

    +1.49%

  • Industrials

    +2.99%

  • Real Estate

    +0.41%

  • Technology

    +1.45%

  • Utilities

    +1.09%

Note: Daily price change (%) by sector excluding stocks with +/-90% daily price change. Companies above $500 million market capitalization are considered.

Support

Hi! How can we help you today?

Loading…